Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy-Reference-Cited by-同舟云学术

Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy

Published:2012-04-23 Issue:13 Volume:18 Page:1784-1795
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

James A. McCubrey ¹,Linda S. Steelman ¹,Stephen L. Abrams ¹,Negin Misaghian ¹,William H. Chappell ,Sanja Mijatovic ¹,Giuseppeo Montalto ¹,Melchiorre Cervello ¹,Piotr Laidler ¹,Antonio Bonati ¹,Camilla Evangelisti ¹,Lucio Cocco ,Alberto M. Martelli ²

Affiliation:

1. Department of Public Health and Community Medicine, Section of Pharmacology, University of Verona, P.le Scuro 10, 37134 Verona, Italy.

2. Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA 27858.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives;memo - Magazine of European Medical Oncology;2024-03-26

2. Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives;Expert Review of Hematology;2023-07-27

3. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer;Cancer Letters;2020-04

4. Blastemal NCAM+ALDH1+ Wilms' tumor cancer stem cells correlate with disease progression and poor clinical outcome: A pilot study;Pathology - Research and Practice;2019-08

5. Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives;Wiener klinische Wochenschrift;2018-07-13